文献速递运动医学关节外科

桶柄状半月板撕裂全内修复的临床结局与预后因素

All-Inside Repair of Bucket-Handle Meniscal Tears: Clinical Outcomes and Prognostic Factors.
PubMed 文献 · Am J Sports Med · 2020-03-20

RapidLoc和Biofix Arrow装置、男性及更长随访时间与更高失败率相关,内外侧修复失败率无差异。

要点

  • 全内修复桶柄状半月板撕裂总体失败率29.3%,平均13.0个月。
  • RapidLoc和Biofix Arrow装置失败率显著高于其他装置。
  • 男性失败率高于女性,随访超过30个月失败率更高。

核心结论

  • 全内修复桶柄状半月板撕裂总体失败率为29.3%,平均失败时间13.0个月。
  • 内侧与外侧半月板修复失败率无显著差异。
  • RapidLoc和Biofix Arrow装置、男性性别及更长随访时间与更高失败率相关。

研究设计与样本

  • 系统综述遵循PRISMA指南,检索3个数据库1993至2019年英文文献。
  • 纳入报告全内修复桶柄状半月板撕裂临床结局且随访≥12个月的研究,由2名独立评审者评估。
  • 研究质量采用Modified Coleman Methodology Score(MCMS)评估,平均54.4 ± 12。

主要发现

  • 使用的6种修复装置失败率分别为:Meniscal Repair System 13.5%,FasT-Fix 22.4%,Meniscus Arrow 27.1%,Biofix Arrow 42.9%,RapidLoc 45.2%,PDS II suture 0%。
  • 总体修复失败率为29.3%,平均失败时间13.0个月(范围5.0-32.4个月),仍在使用的装置失败率为19.0%。
  • RapidLoc和Biofix Arrow失败率高于其他装置(P = .0003);女性失败率31%低于男性69%(P = .03)。
  • 随访>30个月失败率34.4%,<30个月失败率23.4%(P = .016)。
  • 4项比较全内与由内向外修复的研究中,失败率无显著差异;内侧与外侧修复、合并或不合并前交叉韧带重建的失败率均无显著差异(P > .05)。

关键数值与推荐

  • 全内修复桶柄状半月板撕裂总体失败率29.3%,平均失败时间13.0个月。
  • RapidLoc失败率45.2%,Biofix Arrow失败率42.9%,显著高于其他装置(P = .0003)。
  • 男性失败率69%,女性31%(P = .03);随访>30个月失败率34.4%,<30个月23.4%(P = .016)。
  • 内侧与外侧修复失败率无显著差异,合并或不合并前交叉韧带重建的失败率无显著差异(P > .05)。

临床怎么用

  • 选择全内修复装置时需考虑RapidLoc和Biofix Arrow与更高失败率相关。
  • 男性患者及计划更长随访时,应告知更高失败风险并加强监测。
  • 内外侧桶柄状半月板撕裂均可采用全内修复,失败率无差异。

局限性

  • 纳入研究以 level 3和 level 4证据为主,仅1项 level 1研究。
  • 平均MCMS为54.4 ± 12,方法学质量中等。
  • 各装置失败率基于不同研究,未进行直接比较调整。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: There is no consensus on technique of choice for repair of bucket-handle meniscal tears (BHMTs). PURPOSE: To determine factors that affect patient outcomes and failure rates in patients undergoing all-inside repairs of BHMTs. STUDY DESIGN: Systematic review. METHODS: A systematic review of 3 databases using PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines was performed. All English-language literature from 1993 to 2019 describing clinical outcomes for patients undergoing all-inside BHMT repair with ≥12-month follow-up was reviewed by 2 independent reviewers. Patient characteristics (patient sex, age), intraoperative factors (laterality, concomitant procedures, surgical technique, implants utilized), and postoperative outcomes (failure rates) were analyzed. Study quality was evaluated with the Modified Coleman Methodology Score (MCMS). RESULTS: Fifteen studies (1 level 1, 4 level 3, 10 level 4) with 763 total patients (64% male; average age, 26.4 years [range, 9-58 years]; average follow-up, 39.8 months [range, 12-120 months]) including 396 all-inside BHMT repairs were included. Six devices were used for repair including the Meniscal Repair System, FasT-Fix, Meniscus Arrow, Biofix Arrow, RapidLoc device, and PDS II suture, with failure rates of 13.5%, 22.4%, 27.1%, 42.9%, 45.2%, and 0%, respectively. The overall repair failure rate was 29.3% at an average of 13.0 months (range, 5.0-32.4 months), but 19.0% for devices still in use. The RapidLoc and Biofix Arrow had higher failure rates than other devices (P = .0003). Women (31%) were less likely to experience a failure than were men (69%) (P = .03). Longer follow-up duration resulted in higher failure rates (>30 months, 34.4%; <30 months, 23.4%; P = .016). In 4 studies reporting on both all-inside and inside-out repairs, no significant differences in failure rates were observed. No significant differences in failure rates were found between medial and lateral repairs nor repair with and without concurrent anterior cruciate ligament reconstruction (P > .05 for all). The overall average MCMS was 54.4 ± 12. CONCLUSION: The overall failure rate after all-inside repair of BHMTs is 29.3% at an average of 13.0 months, with no difference in failure rates between medial and lateral meniscal repairs. The variables shown to negatively affect the failure rates were the RapidLoc and Biofix Arrow, male sex, and longer follow-up duration.

来源:Am J Sports Med,查看原文。版权归原作者所有。

引用

  1. Ardizzone CA, Houck DA, McCartney DW, et al. All-Inside Repair of Bucket-Handle Meniscal Tears: Clinical Outcomes and Prognostic Factors. Am J Sports Med. 2020. PMID: 32195594. doi:10.1177/0363546520906141

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。